Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia Patients
Phase NA Unknown
51 enrolled
Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Phase 2 Unknown
37 enrolled 15 charts
Comparison Between Peribulbar And Sub-tenon Blocks on Oculocardiac Reflex (OCR) During Pediatric Strabismus Surgery
Phase NA Unknown
140 enrolled
Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL
Phase 2 Unknown
50 enrolled
BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)
Phase 1/2 Unknown
41 enrolled
Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)
Unknown
220 enrolled
SKETCh
Unknown
650 enrolled
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
Phase NA Unknown
20 enrolled
A Phase II Trial of Intermediate Radiation Dose For Lymphoma
Phase NA Unknown
27 enrolled
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Unknown
30 enrolled
Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL
Phase NA Unknown
32 enrolled
Acute Concussion and Melatonin
Phase 2 Unknown
254 enrolled
Vaccination With Flt3L, Radiation, and Poly-ICLC
Phase 1/2 Unknown
56 enrolled
CART-Omic
Phase NA Unknown
20 enrolled
Trial-based Effectiveness and Cost-effectiveness of the Partner in Balance Intervention
Phase NA Unknown
141 enrolled
Chi-GVM Regimen for the Treatment of R/R PTCL
Phase NA Unknown
50 enrolled
BV-AVD-R Treatment Children Hodgkin's Lymphoma
Phase 2 Unknown
44 enrolled
CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy
Unknown
2,500 enrolled
PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors
Unknown
75 enrolled
Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma
Phase 2 Unknown
20 enrolled
COPA-R-CHOP
Phase 2 Unknown
62 enrolled
A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)
Phase 3 Unknown
159 enrolled
AVENuE
Phase 2 Unknown
49 enrolled
Phase â… /â…¡ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas
Phase 1/2 Unknown
100 enrolled
Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study
Unknown
400 enrolled
Turkish Cultural Adaptation, Validity and Reliability of the "Gait Outcomes Assessment List"
Unknown
200 enrolled
Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy
Phase 1 Unknown
81 enrolled
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
Phase NA Unknown
30 enrolled
GAZAI
Phase 2 Unknown
89 enrolled
Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial
Unknown
1,020 enrolled
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Unknown
954 enrolled
ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
Unknown
20 enrolled
Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT
Phase 2 Unknown
28 enrolled
MITRAS
Phase 2 Unknown
140 enrolled
Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy
Unknown
150 enrolled
RONIN
Phase 4 Unknown
30 enrolled
LYMPHODTECT
Phase NA Unknown
74 enrolled
Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab
Phase 1 Unknown
31 enrolled
Lapelga vs Gastrofil
Phase 3 Unknown
74 enrolled
A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients
Phase 1/2 Unknown
42 enrolled
Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
Unknown
300 enrolled
Evaluation of Brain Changes in ALL Patients on Therapy
Phase NA Unknown
110 enrolled
CARdio-Tox
Unknown
48 enrolled
MASSAYA
Unknown
181 enrolled
Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors
Unknown
30 enrolled
Elattar
Unknown
100 enrolled
Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions
Phase NA Unknown
150 enrolled
ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL
Phase 2 Unknown
31 enrolled
Gastric Residual Volumes in Infants Fed at 4 and 6 Hours Prior to General Anaesthesia
Phase NA Unknown
70 enrolled
IMPROVE
Phase 2 Unknown
31 enrolled